Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Digital content

05 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302653067.html

23 Dec 2025
// BIOSPACE
https://www.biospace.com/drug-development/neurocrines-valbenazine-fails-phase-iii-neurodevelopmental-disorder-trial

16 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-showcases-rd-transformation-driving-innovation-across-neuroscience-and-endocrinology-302643635.html

10 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-host-rd-day-on-december-16-302637109.html

23 Nov 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/rd/neurocrine-review-highlights-key-differences-between-tardive-dyskinesia-drugs-18317

20 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-publication-of-landmark-narrative-review-on-fda-approved-vmat2-inhibitors-demonstrating-unique-profile-of-ingrezza-valbenazine-capsules-302620990.html
ABOUT THIS PAGE